Kura Oncology (KURA) Receivables (2024 - 2026)
Kura Oncology (KURA) posted quarterly Receivables of $9.3 million for Q1 2026, down 80.82% year-over-year from $48.7 million in Q1 2025, and up 6.18% quarter-over-quarter from $8.8 million in Q4 2025.
Kura Oncology (KURA) Receivables (2024 - 2026) Analysis & Trends
Kura Oncology (KURA) has reported Receivables for 3 consecutive years, with $9.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables fell 80.82% year-over-year to $9.3 million; the TTM figure through Mar 2026 stood at $9.3 million (down 80.82% YoY), while the FY2025 annual figure was $8.8 million, up 327.38% from the prior year.
- Receivables grew to $9.3 million in Q1 2026 per KURA's latest filing, from $8.8 million in the prior quarter.
- Across five years, Receivables topped out at $48.7 million in Q1 2025 and bottomed at $2.1 million in Q4 2024.
- Historically, Receivables has averaged $18.2 million across 3 years, with a median of $9.1 million in 2025.
- Annual changes were most pronounced in 2025 — Receivables soared 327.38% — and 2026, when it plunged 80.82%.
- Kura Oncology's Receivables stood at $2.1 million in 2024, then jumped by 327.38% to $8.8 million in 2025, then gained by 6.18% to $9.3 million in 2026.
- Business Quant data shows KURA's Receivables at $9.3 million in Q1 2026, $8.8 million in Q4 2025, and $35.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Kura Oncology | 966.11 Mn | 966.11 Mn | 20.63 Mn | 9.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.45 Mn |
| Mar 31, 2026 | 9.35 Mn |
| Dec 31, 2025 | 8.80 Mn |
| Sep 30, 2025 | 35.94 Mn |
| Jun 30, 2025 | 4.57 Mn |
| Mar 31, 2025 | 48.75 Mn |
| Dec 31, 2024 | 2.06 Mn |